Ulivi P - Search Results

1

Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer.

De Matteis S, Canale M, Verlicchi A, Bronte G, Delmonte A, Crinò L, Martinelli G, Ulivi P. De Matteis S, et al. Among authors: ulivi p. J Oncol. 2019 Aug 19;2019:7475364. doi: 10.1155/2019/7475364. eCollection 2019. J Oncol. 2019. PMID: 31531020 Free PMC article. Review.

2

Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients.

Ulivi P, Romagnoli M, Chiadini E, Casoni GL, Capelli L, Gurioli C, Zoli W, Saragoni L, Dubini A, Tesei A, Amadori D, Poletti V. Ulivi P, et al. Int J Oncol. 2012 Jul;41(1):147-52. doi: 10.3892/ijo.2012.1432. Epub 2012 Apr 10. Int J Oncol. 2012. PMID: 22504767

3

Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer.

Ulivi P, Silvestrini R. Ulivi P, et al. Cell Oncol (Dordr). 2013 Dec;36(6):439-48. doi: 10.1007/s13402-013-0155-3. Epub 2013 Nov 1. Cell Oncol (Dordr). 2013. PMID: 24177991 Review.

4

Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation.

Ulivi P, Zoli W, Capelli L, Chiadini E, Calistri D, Amadori D. Ulivi P, et al. Mol Clin Oncol. 2013 Jul;1(4):575-581. doi: 10.3892/mco.2013.100. Epub 2013 Mar 29. Mol Clin Oncol. 2013. PMID: 24649213 Free PMC article. Review.

5

Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?

Ulivi P, Delmonte A, Chiadini E, Calistri D, Papi M, Mariotti M, Verlicchi A, Ragazzini A, Capelli L, Gamboni A, Puccetti M, Dubini A, Burgio MA, Casanova C, Crinò L, Amadori D, Dazzi C. Ulivi P, et al. Int J Mol Sci. 2014 Dec 31;16(1):747-57. doi: 10.3390/ijms16010747. Int J Mol Sci. 2014. PMID: 25561229 Free PMC article.

6

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab.

Chiadini E, Scarpi E, Passardi A, Calistri D, Valgiusti M, Saragoni L, Zoli W, Amadori D, Ulivi P. Chiadini E, et al. Among authors: ulivi p. Oncol Lett. 2015 Mar;9(3):1432-1438. doi: 10.3892/ol.2015.2876. Epub 2015 Jan 14. Oncol Lett. 2015. PMID: 25663927 Free PMC article.

7

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.

Ulivi P, Chiadini E, Dazzi C, Dubini A, Costantini M, Medri L, Puccetti M, Capelli L, Calistri D, Verlicchi A, Gamboni A, Papi M, Mariotti M, De Luigi N, Scarpi E, Bravaccini S, Turolla GM, Amadori D, Crinò L, Delmonte A. Ulivi P, et al. Clin Lung Cancer. 2016 Sep;17(5):384-390. doi: 10.1016/j.cllc.2015.11.004. Epub 2015 Dec 1. Clin Lung Cancer. 2016. PMID: 26712101

8

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report.

Casadei Gardini A, Chiadini E, Faloppi L, Marisi G, Delmonte A, Scartozzi M, Loretelli C, Lucchesi A, Oboldi D, Dubini A, Frassineti GL, Ulivi P. Casadei Gardini A, et al. Among authors: ulivi p. BMC Cancer. 2016 Jul 7;16:429. doi: 10.1186/s12885-016-2463-2. BMC Cancer. 2016. PMID: 27388325 Free PMC article.

9

Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors.

Canale M, Petracci E, Delmonte A, Chiadini E, Dazzi C, Papi M, Capelli L, Casanova C, De Luigi N, Mariotti M, Gamboni A, Chiari R, Bennati C, Calistri D, Ludovini V, Crinò L, Amadori D, Ulivi P. Canale M, et al. Among authors: ulivi p. Clin Cancer Res. 2017 May 1;23(9):2195-2202. doi: 10.1158/1078-0432.CCR-16-0966. Epub 2016 Oct 25. Clin Cancer Res. 2017. PMID: 27780855

10

Immune Checkpoints as a Target for Colorectal Cancer Treatment.

Passardi A, Canale M, Valgiusti M, Ulivi P. Passardi A, et al. Among authors: ulivi p. Int J Mol Sci. 2017 Jun 21;18(6):1324. doi: 10.3390/ijms18061324. Int J Mol Sci. 2017. PMID: 28635639 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page